Akero Therapeutics, Inc.

AKRO · NASDAQ
Analyze with AI
$54.65+$0.00 (+0%)
At close:Dec 9, 2025, 9:00 PM UTC
$54.65+$0.00 (+0%)
After hours:Dec 9, 2025, 2:30 PM UTC
P/E TTM-15.73
P/B TTM4.35
P/S TTM1,124,645.08
Dividend Yield0%
EPS-$3.75
Beta-0.404
Valuation
PEG Ratio11.80
FCF Yield-5.63%
EV / EBITDA-15.46
Quality
ROIC-30.23%
Gross Margin25.00%
Cash Conv. Ratio0.89
Growth
Revenue 3Y CAGR
FCF Growth-58.29%
Safety
Net Debt / EBITDA0.66
Interest Coverage-67.37
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-1,611,961.67

Akero Therapeutics, Inc. (AKRO) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Akero Therapeutics, Inc. (AKRO) stock price today?

As of Dec 9, 2025, 9:00 PM UTC, Akero Therapeutics, Inc. (AKRO) stock is trading at $54.65. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date AKRO stock quotes for informed trading decisions.

What is Akero Therapeutics, Inc.'s market capitalization?

Akero Therapeutics, Inc. (AKRO) has a market capitalization of approximately $4.5B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Akero Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the AKRO stock price changes.

What is the 52-week range for Akero Therapeutics, Inc. stock?

Akero Therapeutics, Inc. (AKRO) stock has traded in a 52-week range of $21.34 — $58.40. The 52-week range shows the highest and lowest prices at which AKRO traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Akero Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Akero Therapeutics, Inc. stock have?

Akero Therapeutics, Inc. (AKRO) stock recently traded approximately 11.6M shares. Trading volume indicates market liquidity and investor interest in AKRO. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Akero Therapeutics, Inc. stock.

Does Akero Therapeutics, Inc. pay dividends to shareholders?

Yes, Akero Therapeutics, Inc. (AKRO) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Akero Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Akero Therapeutics, Inc.'s intraday price range?

Today, Akero Therapeutics, Inc. (AKRO) stock has traded in a range of $54.52 — $54.65. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring AKRO's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Akero Therapeutics, Inc. stock data?

AlphaPilot sources real-time AKRO stock quotes, fundamental financial data, and historical price charts for Akero Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Akero Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of AKRO stock performance.